Articles related to DRY EYE DISEASE (DED)

Researchers at the National University of Singapore developed a spinach-derived nanotechnology delivering plant photosynthetic machinery into corneal cells via eye drops, demonstrating reversal of corneal damage to near-healthy levels within five days in preclinical models of dry eye disease.

Reproxalap is an investigational drug candidate for the treatment of dry eye disease.

Discover how Miebo, supported by phase 3 clinical trials, offers a unique approach to dry eye disease by specifically targeting tear evaporation.

Learn how an integrative approach involving specialty lenses and pharmaceuticals can revolutionize treatment strategies for ocular and corneal conditions.

The study underscores the limitations of relying on single tests for diagnosing dry eye disease and advocates for a multi-test approach to enhance diagnostic accuracy. Explore how combining specific tests can significantly improve your diagnostic outcomes.

Look into the potential of using autologous serum eye drops to treat dry eyes. Despite marginal gains in symptoms and staining scores, the effectiveness overall is still unclear. Explore the study’s findings in greater detail to comprehend how dry eye treatment will develop.